$YCBD
cbdMD, Inc. Stock $ycbd

$ycbd Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-Q Financial Statement

#000143774923003144 Filed on February 13, 2023

Income Statement

Concept	2023 Q1	2022 Q4
Revenue	$6.240M	$6.085M
YoY Change	-35.19%	-34.72%
Cost Of Revenue	$2.225M	$2.517M
YoY Change	-30.19%	-41.84%
Gross Profit	$4.016M	$3.568M
YoY Change	-37.67%	-28.55%
Gross Profit Margin	64.35%	58.63%
Selling, General & Admin	$3.997M	$5.442M
YoY Change	-80.71%	-49.83%
% of Gross Profit	99.53%	152.54%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$277.4K	$100.1K
YoY Change	-14.21%	-70.62%
% of Gross Profit	6.91%	2.81%
Operating Expenses	$4.531M	$6.729M
YoY Change	-60.44%	-43.71%
Operating Profit	-$1.401M	-$4.046M
YoY Change	-72.05%	-83.91%
Interest Expense	-$1.950K	$29.12K
YoY Change	-94.96%	-179.61%
% of Operating Profit
Other Income/Expense, Net	$17.79K	$0.00
YoY Change	-75.63%	-100.0%
Pretax Income	-$1.337M	-$3.956M
YoY Change	-71.3%	-79.35%
Income Tax	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$1.337M	-$3.956M
YoY Change	-71.3%	-79.35%
Net Earnings / Revenue	-21.42%	-65.01%
Basic Earnings Per Share	-$1.74	-$0.08
Diluted Earnings Per Share	-$1.74	-$0.08
COMMON SHARES
Basic Shares Outstanding	65.43M	60.68M
Diluted Shares Outstanding	1.346M	60.36M

Balance Sheet

Concept	2023 Q1	2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.719M	$4.353M
YoY Change	-88.01%	-78.97%
Cash & Equivalents	$1.719M	$3.353M
Short-Term Investments	$0.00	$1.000M
Other Short-Term Assets	$2.734M	$1.587M
YoY Change	-15.39%	-47.19%
Inventory	$4.532M	$4.861M
Prepaid Expenses
Receivables	$338.5K	$265.5K
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$10.15M	$11.53M
YoY Change	-58.29%	-61.15%
LONG-TERM ASSETS
Property, Plant & Equipment	$798.2K	$900.6K
YoY Change	-65.81%	-64.04%
Goodwill
YoY Change
Intangibles	$17.28M	$17.56M
YoY Change	-6.03%	-5.94%
Long-Term Investments	$1.400M	$1.400M
YoY Change
Other Assets	$138.7K	$138.7K
YoY Change	0.0%	-65.98%
Total Long-Term Assets	$23.54M	$24.20M
YoY Change	-65.72%	-65.26%
TOTAL ASSETS
Total Short-Term Assets	$10.15M	$11.53M
Total Long-Term Assets	$23.54M	$24.20M
Total Assets	$33.68M	$35.73M
YoY Change	-63.78%	-64.03%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.338M	$1.690M
YoY Change	-51.3%	-54.01%
Accrued Expenses	$2.107M	$2.650M
YoY Change	-29.21%	-12.43%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$7.380K	$9.760K
YoY Change	-88.0%	-83.86%
Total Short-Term Liabilities	$4.679M	$5.552M
YoY Change	-19.11%	-17.87%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change	-100.0%	-100.0%
Other Long-Term Liabilities	$3.218M	$3.584M
YoY Change	-54.68%	-55.61%
Total Long-Term Liabilities	$3.218M	$3.584M
YoY Change	-55.17%	-56.11%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.679M	$5.552M
Total Long-Term Liabilities	$3.218M	$3.584M
Total Liabilities	$7.898M	$9.136M
YoY Change	-39.08%	-38.79%
SHAREHOLDERS EQUITY
Retained Earnings	-$154.7M	-$152.4M
YoY Change	56.03%	62.97%
Common Stock	$1.457K	$60.71K
YoY Change	-97.55%	4.18%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$25.79M	$26.59M
YoY Change
Total Liabilities & Shareholders Equity	$33.68M	$35.73M
YoY Change	-63.78%	-64.03%

Cashflow Statement

Concept	2023 Q1	2022 Q4
OPERATING ACTIVITIES
Net Income	-$1.337M	-$3.956M
YoY Change	-71.3%	-79.35%
Depreciation, Depletion And Amortization	$277.4K	$100.1K
YoY Change	-14.21%	-70.62%
Cash From Operating Activities	-$1.734M	-$2.064M
YoY Change	-66.67%	-62.25%
INVESTING ACTIVITIES
Capital Expenditures	-$102.4K	$177.4K
YoY Change	-28.28%	-176.77%
Acquisitions
YoY Change
Other Investing Activities	$1.000M
YoY Change
Cash From Investing Activities	$1.102M	-$177.4K
YoY Change	-872.14%	-23.23%
FINANCING ACTIVITIES
Cash Dividend Paid	$1.001M	$1.001M
YoY Change	0.0%	0.0%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-1.003M	-$1.126M
YoY Change	-1.22%	10.92%
NET CHANGE
Cash From Operating Activities	-1.734M	-$2.064M
Cash From Investing Activities	1.102M	-$177.4K
Cash From Financing Activities	-1.003M	-$1.126M
Net Change In Cash	-1.634M	-$3.368M
YoY Change	-74.31%	-49.85%
FREE CASH FLOW
Cash From Operating Activities	-$1.734M	-$2.064M
Capital Expenditures	-$102.4K	$177.4K
Free Cash Flow	-$1.631M	-$2.242M
YoY Change	-67.76%	-57.2%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q4	dei	Amendment Flag AmendmentFlag	false
CY2022Q4	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--09-30
CY2022Q4	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2022Q4	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	5000000
CY2022Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	5000000
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	5000000
CY2022Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	5000000
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	60712262
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	60712262
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	60665595
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	60665595
CY2022Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	0	usd
CY2022Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	0	usd
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	60712262
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	60665595
CY2022Q4	dei	Document Type DocumentType	10-Q
CY2022Q4	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2022Q4	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022Q4	dei	Document Transition Report DocumentTransitionReport	false
CY2022Q4	dei	Entity File Number EntityFileNumber	001-38299
CY2022Q4	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NC
CY2022Q4	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	47-3414576
CY2022Q4	dei	Entity Address Address Line1 EntityAddressAddressLine1	8845 Red Oak Blvd
CY2022Q4	dei	Entity Address City Or Town EntityAddressCityOrTown	Charlotte
CY2022Q4	dei	Entity Address State Or Province EntityAddressStateOrProvince	NC
CY2022Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	898720	usd
CY2022Q3	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	1447831	usd
CY2022Q4	us-gaap	Disposal Group Including Discontinued Operation Accounts Notes And Loans Receivable Net DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet	0	usd
CY2022Q4	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	28217
CY2022Q4	dei	City Area Code CityAreaCode	704
CY2022Q4	dei	Local Phone Number LocalPhoneNumber	445-3060
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	9758	usd
CY2022Q3	us-gaap	Notes Payable Current NotesPayableCurrent	9609	usd
CY2022Q4	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022Q4	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022Q4	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022Q4	dei	Entity Small Business EntitySmallBusiness	true
CY2022Q4	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2022Q4	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2022Q4	dei	Entity Shell Company EntityShellCompany	false
CY2022Q3	us-gaap	Disposal Group Including Discontinued Operation Accounts Notes And Loans Receivable Net DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet	1375	usd
CY2022Q4	us-gaap	Other Short Term Investments OtherShortTermInvestments	1000000	usd
CY2022Q3	us-gaap	Other Short Term Investments OtherShortTermInvestments	1000000	usd
CY2022Q4	us-gaap	Inventory Gross InventoryGross	4690609	usd
CY2022Q3	us-gaap	Inventory Gross InventoryGross	4255914	usd
CY2022Q4	ycbd	Prepaid Inventory PrepaidInventory	170659	usd
CY2022Q3	ycbd	Prepaid Inventory PrepaidInventory	511459	usd
CY2022Q4	ycbd	Prepaid Sponsorship PrepaidSponsorship	66784	usd
CY2022Q3	ycbd	Prepaid Sponsorship PrepaidSponsorship	1372845	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1349784	usd
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	65429686
CY2022Q3	us-gaap	Other Assets OtherAssets	24780306	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3352664	usd
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6720234	usd
CY2022Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	701945	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	11529220	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	16011603	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	900567	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	823310	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4201204	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4477841	usd
CY2022Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	138708	usd
CY2022Q3	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	244606	usd
CY2022Q4	us-gaap	Assets Assets	35726893	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	17557194	usd
CY2022Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	17834549	usd
CY2022Q4	us-gaap	Other Long Term Investments OtherLongTermInvestments	1400000	usd
CY2022Q3	us-gaap	Other Long Term Investments OtherLongTermInvestments	1400000	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	24197673	usd
CY2022Q3	us-gaap	Assets Assets	40791909	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1689527	usd
CY2022Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	2036558	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2650337	usd
CY2022Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2060762	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1202797	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1178683	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5552419	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-3956062	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	5285612	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	0	usd
CY2022Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	125491	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3368713	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3680375	usd
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	215000	usd
CY2022Q3	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	276000	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	3583713	usd
CY2022Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	4081866	usd
CY2022Q4	us-gaap	Liabilities Liabilities	9136132	usd
CY2022Q3	us-gaap	Liabilities Liabilities	9367478	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	5000	usd
CY2022Q3	us-gaap	Preferred Stock Value PreferredStockValue	5000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	60712	usd
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	60666	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	178905176	usd
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	178782328	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-152380127	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-147423563	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	26590761	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	31424431	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	35726893	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	40791909	usd
CY2022Q4	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	6240526	usd
CY2021Q4	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	9856767	usd
CY2022Q4	ycbd	Sales Allowances SalesAllowances	155308	usd
CY2021Q4	ycbd	Sales Allowances SalesAllowances	534945	usd
CY2022Q4	us-gaap	Revenues Revenues	6085218	usd
CY2021Q4	us-gaap	Revenues Revenues	9321822	usd
CY2022Q4	us-gaap	Cost Of Revenue CostOfRevenue	2517452	usd
CY2021Q4	us-gaap	Cost Of Revenue CostOfRevenue	4328310	usd
CY2022Q4	us-gaap	Gross Profit GrossProfit	3567766	usd
CY2021Q4	us-gaap	Gross Profit GrossProfit	4993512	usd
CY2022Q4	ycbd	Operating Expenses Excluding Impairment OperatingExpensesExcludingImpairment	7613947	usd
CY2021Q4	ycbd	Operating Expenses Excluding Impairment OperatingExpensesExcludingImpairment	11955284	usd
CY2022Q4	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	usd
CY2021Q4	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	18183285	usd
CY2022Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-4046181	usd
CY2021Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-25145057	usd
CY2022Q4	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	0	usd
CY2021Q4	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	-33351	usd
CY2022Q4	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-61000	usd
CY2021Q4	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-5950000	usd
CY2022Q4	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	usd
CY2021Q4	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	70738	usd
CY2022Q4	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	29119	usd
CY2021Q4	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-3234	usd
CY2022Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3956062	usd
CY2021Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-19160904	usd
CY2022Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-0	usd
CY2021Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-0	usd
CY2021Q4	us-gaap	Net Income Loss NetIncomeLoss	-19160904	usd
CY2022Q4	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	1000502	usd
CY2021Q4	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	1000502	usd
CY2022Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-4956564	usd
CY2021Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-20161406	usd
CY2022Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
CY2021Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.35
CY2022Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.08
CY2021Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.35
CY2022Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	60357449
CY2021Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	57825367
CY2022Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	60357449
CY2021Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	57825367
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-3956062	usd
CY2021Q4	us-gaap	Net Income Loss NetIncomeLoss	-19160904	usd
CY2022Q4	ycbd	Comprehensive Income Loss Net Of Tax Attributable To Parent Before Income Adjustments ComprehensiveIncomeLossNetOfTaxAttributableToParentBeforeIncomeAdjustments	-3956062	usd
CY2021Q4	ycbd	Comprehensive Income Loss Net Of Tax Attributable To Parent Before Income Adjustments ComprehensiveIncomeLossNetOfTaxAttributableToParentBeforeIncomeAdjustments	-19160904	usd
CY2022Q4	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	1000502	usd
CY2021Q4	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	1000502	usd
CY2022Q4	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-4956564	usd
CY2021Q4	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-20161406	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-3956062	usd
CY2021Q4	us-gaap	Net Income Loss NetIncomeLoss	-19160904	usd
CY2022Q4	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	79446	usd
CY2021Q4	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	505466	usd
CY2022Q4	us-gaap	Restricted Stock Expense RestrictedStockExpense	43449	usd
CY2021Q4	us-gaap	Restricted Stock Expense RestrictedStockExpense	508754	usd
CY2022Q4	ycbd	Write Off Of Prepaid Assets WriteOffOfPrepaidAssets	884892	usd
CY2021Q4	ycbd	Write Off Of Prepaid Assets WriteOffOfPrepaidAssets	0	usd
CY2022Q4	ycbd	Marketing Stock Amortization MarketingStockAmortization	0	usd
CY2021Q4	ycbd	Marketing Stock Amortization MarketingStockAmortization	220000	usd
CY2022Q4	us-gaap	Inventory Write Down InventoryWriteDown	0	usd
CY2021Q4	us-gaap	Inventory Write Down InventoryWriteDown	878142	usd
CY2022Q4	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	277354	usd
CY2021Q4	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	0	usd
CY2022Q4	us-gaap	Depreciation Depreciation	100112	usd
CY2021Q4	us-gaap	Depreciation Depreciation	340701	usd
CY2022Q4	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	usd
CY2021Q4	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	18183285	usd
CY2022Q4	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-61000	usd
CY2021Q4	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-5950000	usd
CY2022Q4	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	-0	usd
CY2021Q4	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	-33351	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	276636	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	318017	usd
CY2022Q4	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-549111	usd
CY2021Q4	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-4554	usd
CY2022Q4	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	-105898	usd
CY2021Q4	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	-121875	usd
CY2022Q4	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	434695	usd
CY2021Q4	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	723483	usd
CY2022Q4	ycbd	Increase Decrease In Prepaid Inventory Total IncreaseDecreaseInPrepaidInventoryTotal	-340799	usd
CY2021Q4	ycbd	Increase Decrease In Prepaid Inventory Total IncreaseDecreaseInPrepaidInventoryTotal	8189	usd
CY2022Q4	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	226670	usd
CY2021Q4	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	303391	usd
CY2022Q4	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	39204	usd
CY2021Q4	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-127254	usd
CY2022Q4	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-287547	usd
CY2021Q4	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-321464	usd
CY2022Q4	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	203341	usd
CY2021Q4	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	3723	usd
CY2022Q4	ycbd	Collection On Discontinued Operations Accounts Receivable CollectionOnDiscontinuedOperationsAccountsReceivable	1375	usd
CY2021Q4	ycbd	Collection On Discontinued Operations Accounts Receivable CollectionOnDiscontinuedOperationsAccountsReceivable	8342	usd
CY2022Q4	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2064357	usd
CY2021Q4	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5468475	usd
CY2022Q4	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	177370	usd
CY2021Q4	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	231030	usd
CY2022Q4	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-177370	usd
CY2021Q4	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-231030	usd
CY2022Q4	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	-125341	usd
CY2021Q4	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	-14498	usd
CY2022Q4	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	1000502	usd
CY2021Q4	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	1000502	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-6714505	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	6720234	usd
CY2022Q4	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1125843	usd
CY2021Q4	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1015000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-3367570	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	26411424	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	3352664	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	19696919	usd
CY2022Q4	us-gaap	Interest Paid Net InterestPaidNet	2638	usd
CY2021Q4	us-gaap	Interest Paid Net InterestPaidNet	3234	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	31424431	usd
CY2022Q4	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	0	usd
CY2022Q4	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	43448	usd
CY2022Q4	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	1000502	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-3956062	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	26590761	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	103142187	usd
CY2021Q4	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	405000	usd
CY2021Q4	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	505466	usd
CY2021Q4	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	508754	usd
CY2021Q4	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	1000502	usd
CY2021Q4	us-gaap	Net Income Loss NetIncomeLoss	-19160904	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	84400000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	2047	usd
CY2022Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	36980	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	265477	usd
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	273451	usd
CY2022Q4	us-gaap	Revenues Revenues	6085218	usd
CY2021Q4	us-gaap	Revenues Revenues	9321822	usd
CY2022Q4	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"/> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Concentrations</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Financial instruments that potentially expose the Company to concentrations of credit risk consist primarily of cash and cash equivalents, accounts receivable, and securities.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company places its cash and cash equivalents on deposit with financial institutions in the United States. The Federal Deposit Insurance Corporation (“FDIC”) covers $250,000 for substantially all depository accounts. The Company from time to time <em style="font: inherit;"> may </em>have amounts on deposit in excess of the insured limits. The Company had a $2.7 million uninsured balance at <em style="font: inherit;"> December 31, 2022</em> and a $5.8 million uninsured balance at <em style="font: inherit;"> September 30, 2022</em>.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Concentration of credit risk with respect to receivables is principally limited to trade receivables with corporate customers that meet specific credit policies. Management considers these customer receivables to represent normal business risk. The Company did <span style="-sec-ix-hidden:c92857309">not</span> have any customers that represented a significant amount of our sales for the <em style="font: inherit;">three</em> months ended <em style="font: inherit;"> December 31, 2022</em>.</p>
CY2022	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	250000	usd
CY2022Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	2700000	usd
CY2022Q3	us-gaap	Cash Uninsured Amount CashUninsuredAmount	5800000	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-3956062	usd
CY2022Q4	ycbd	Working Capital WorkingCapital	5977801	usd
CY2022Q4	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	0	usd
CY2021Q4	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	33350	usd
CY2022Q1	ycbd	Total Acquisition Shares TotalAcquisitionShares	1042193
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	3374260	usd
CY2022Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	3198488	usd
CY2022Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	1373933	usd
CY2022Q3	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	1213724	usd
CY2022Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	57584	usd
CY2022Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	156298	usd
CY2022Q4	ycbd	Prepaid Inventory PrepaidInventory	170659	usd
CY2022Q3	ycbd	Prepaid Inventory PrepaidInventory	511459	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	4861268	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	4767373	usd
CY2021Q4	us-gaap	Inventory Write Down InventoryWriteDown	878142	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2055039	usd
CY2022Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1877671	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1154472	usd
CY2022Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1054361	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	900567	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	823310	usd
CY2022Q4	us-gaap	Depreciation Excluding Lessor Asset Under Operating Lease DepreciationExcludingLessorAssetUnderOperatingLease	100112	usd
CY2021Q4	us-gaap	Depreciation Excluding Lessor Asset Under Operating Lease DepreciationExcludingLessorAssetUnderOperatingLease	288384	usd
CY2021Q4	us-gaap	Goodwill Goodwill	42772685	usd
CY2022Q4	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived		usd
CY2022	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	4285000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1210217	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	932862	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	17557194	usd
CY2022Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	17834549	usd
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	1000502	usd
CY2021Q4	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	1000502	usd
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	60712262
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	60665595
CY2021Q4	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	466713
CY2021Q4	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	25000
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2502500
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.36
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y6M18D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	100000
CY2022Q4	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.25
CY2022Q4	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	-0
CY2022Q4	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	340000
CY2022Q4	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	3.41
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2262500
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.43
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y2M1D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1740833
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	4.10
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y3M
CY2022Q4	ycbd	Class Of Warrant Or Right Grants In Period ClassOfWarrantOrRightGrantsInPeriod	0
CY2022Q4	ycbd	Class Of Warrant Or Right Grants In Period Weighted Average Exercise Price ClassOfWarrantOrRightGrantsInPeriodWeightedAverageExercisePrice	0
CY2022Q4	ycbd	Class Of Warrant Or Right Exercises In Period ClassOfWarrantOrRightExercisesInPeriod	-0
CY2022Q4	ycbd	Class Of Warrant Or Right Exercises In Period Weighted Average Exercise Price ClassOfWarrantOrRightExercisesInPeriodWeightedAverageExercisePrice	0
CY2022Q4	ycbd	Class Of Warrant Or Right Forfeitures In Period ClassOfWarrantOrRightForfeituresInPeriod	100000
CY2022Q4	ycbd	Class Of Warrant Or Right Forfeitures In Period Weighted Average Exercise Price ClassOfWarrantOrRightForfeituresInPeriodWeightedAverageExercisePrice	7.50
CY2022Q4	ycbd	Class Of Warrant Or Right Expirations In Period ClassOfWarrantOrRightExpirationsInPeriod	100000
CY2022Q4	ycbd	Class Of Warrant Or Right Exercisable ClassOfWarrantOrRightExercisable	489917
CY2022Q4	ycbd	Class Of Warrant Or Right Exercisable Weighted Average Exercise Price ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice	4.10
CY2022Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-4956564	usd
CY2021Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-20161406	usd
CY2022Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	60357449
CY2022Q4	us-gaap	Operating Lease Cost OperatingLeaseCost	332124	usd
CY2021Q4	us-gaap	Operating Lease Cost OperatingLeaseCost	386783	usd
CY2022Q4	us-gaap	Operating Lease Payments OperatingLeasePayments	343035	usd
CY2021Q4	us-gaap	Operating Lease Payments OperatingLeasePayments	390227	usd
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y4M17D
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0466	pure
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	1037169	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1421610	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1159949	usd
CY2022Q4	ycbd	Lessee Operating Lease Liability To Be Paid After Year Three LesseeOperatingLeaseLiabilityToBePaidAfterYearThree	1372862	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	4991590	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	420079	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	4571511	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-3956062	usd
CY2021Q4	us-gaap	Net Income Loss NetIncomeLoss	-19160904	usd
CY2022Q4	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	1000502	usd
CY2021Q4	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	1000502	usd
CY2021Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	57825367
CY2022Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	60357449
CY2021Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	57825367
CY2022Q4	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Basic NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic	-4956564	usd
CY2021Q4	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Basic NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic	-20161406	usd
CY2022Q4	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.08
CY2021Q4	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.35
CY2022Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
CY2021Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.35
CY2022Q4	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.08
CY2021Q4	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.35
CY2022Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.08
CY2021Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.35
CY2018Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	4600000	usd
CY2022Q3	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd

Files In Submission

Name	View Source	Status
0001437749-23-003144-index-headers.html	Edgar Link	pending
0001437749-23-003144-index.html	Edgar Link	pending
0001437749-23-003144.txt	Edgar Link	pending
0001437749-23-003144-xbrl.zip	Edgar Link	pending
ex_459521.htm	Edgar Link	pending
ex_459522.htm	Edgar Link	pending
ex_459523.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
img01.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
ycbd-20221231.xsd	Edgar Link	pending
ycbd20221231_10q.htm	Edgar Link	pending
ycbd_10qimg1.jpg	Edgar Link	pending
ycbd_10qimg3.jpg	Edgar Link	pending
ycbd_10qimg4.jpg	Edgar Link	pending
ycbd_10qimg5.jpg	Edgar Link	pending
ycbd-20221231_def.xml	Edgar Link	unprocessable
ycbd-20221231_lab.xml	Edgar Link	unprocessable
ycbd-20221231_pre.xml	Edgar Link	unprocessable
ycbd20221231_10q_htm.xml	Edgar Link	completed
ycbd-20221231_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$YCBD
cbdMD, Inc. Stock $ycbd

2023 Q1 Form 10-Q Financial Statement

#000143774923003144 Filed on February 13, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$YCBD cbdMD, Inc. Stock $ycbd

2023 Q1 Form 10-Q Financial Statement

#000143774923003144 Filed on February 13, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$YCBD
cbdMD, Inc. Stock $ycbd